New screening guidelines suggest PSA cutoff of 2.5
Hollywood, FL--The National Comprehensive Cancer Network (NCCN) has issuednew prostate cancer screening guidelines with several significant changes.The new guidelines suggest, but do not unequivocally mandate, screeningall men aged 50 years and older who have a greater than 10-year life expectancyand initiating biopsies if PSA exceeds 2.5 ng/mL.
Jessica Feehan, NP-C, discusses the expanding role of APPs in urology, from clinical leadership and procedures to care coordination and treatment initiation.
Sam S. Chang, MD, MBA, discusses treatment selection after BCG failure, including bladder-sparing options, cystectomy considerations, and the need for sequencing data.
Justin B. Ziemba, MD, discusses clinical factors that help identify patients at increased risk for kidney stone recurrence and guide metabolic evaluation.
Adam Sharp, PhD, BM, MRCP, BSc, discusses preliminary safety and efficacy findings from a phase 1/2 study of gedatolisib plus darolutamide in patients with mCRPC.